Topical ruxolitinib for the treatment of granuloma faciale

JAAD Case Rep. 2023 Apr 24:36:73-74. doi: 10.1016/j.jdcr.2023.04.013. eCollection 2023 Jun.
No abstract available

Keywords: JAK inhibitor; eosinophil-associated dermatosis; granuloma faciale; interferon-gamma; interleukin-5; janus kinase; pathogenesis; ruxolitinib; topical ruxolitinib; treatment.

Publication types

  • Case Reports